Lifeist Appoints Andrea Judge CEO of Mikra Cellular Sciences
July 03, 2024 07:00 ET
|
Lifeist Wellness Inc.
Lifeist Appoints Andrea Judge CEO of Mikra Cellular Sciences
Global Energy Balls Market Analysis, Competitive Strategies and Forecasts, 2024-2032: Rising Popularity of Plant-Based and Organic Products, Innovative Flavor Combinations and Product Diversity
July 02, 2024 09:16 ET
|
Research and Markets
Dublin, July 02, 2024 (GLOBE NEWSWIRE) -- The "Global Energy Balls Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and...
Global Functional Food Ingredients Market Forecast to 2029 with Cargill, BASF, ADM, International Flavors & Fragrances, Arla Foods, Kerry, Ajinomoto, DSM, Ingredion, and Tate & Lyle Dominating
July 01, 2024 04:08 ET
|
Research and Markets
Dublin, July 01, 2024 (GLOBE NEWSWIRE) -- The "Global Functional Food Ingredients Market by Type (Probiotics, Protein & Amino Acids, Phytochemicals & Plant Extracts, Prebiotics, Omega-3...
Noom Introduces AI-Enabled Products to Enhance On-Demand Health Care and Interactive Coaching
June 27, 2024 08:04 ET
|
Noom Inc
Noom launches two state-of-the-art AI-powered features, AI food logging and Welli, Noom’s new AI personal health assistant.
Lifeist Explores Legal Options Regarding Hedge Fund Settlement
June 27, 2024 07:00 ET
|
Lifeist Wellness Inc.
TORONTO, June 27, 2024 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B0) (OTCMKTS: LFSWF), a health-tech company that leverages advancements in...
Lifeist Wellness Inc. Signs Agreements with Simply Solventless Concentrates Ltd.
June 25, 2024 17:29 ET
|
Lifeist Wellness Inc.
Lifeist enters into agreement with Simply Solventless
The Nair Experience: Unveiling Smooth, Radiant Skin This Summer
June 20, 2024 05:00 ET
|
Nair
This summer, achieve the smooth, radiant skin you deserve with the Nair experience.
Avextra AG and SynQube GmbH announce a Strategic Partnership in Drug Development with Cannabinoids and other Psychotropic Substances
June 20, 2024 01:00 ET
|
Avextra AG
Avextra, the leading European vertically-integrated manufacturer and developer of cannabis-based medicines, is expanding its pharmaceutical development capabilities. Behind SynQube GmbH are the two...
Avextra und SynQube GmbH geben eine strategische Partnerschaft in der Arzneimittelentwicklung mit Cannabinoiden und anderen psychotropen Substanzen bekannt
June 20, 2024 01:00 ET
|
Avextra AG
Avextra, der führende europäische vertikal integrierte Hersteller und Entwickler von Medikamenten auf Cannabisbasis, erweitert nach Abschluss seiner Finanzierungsrunde im ersten Quartal 2024 seine...
Avextra AG and SynQube GmbH announce a Strategic Partnership in Drug Development with Cannabinoids and other Psychotropic Substances
June 20, 2024 01:00 ET
|
Avextra AG
Avextra, the leading European vertically-integrated manufacturer and developer of cannabis-based medicines is expanding its pharmaceutical development capabilities. Behind SynQube GmbH are the two...